Procter & Gamble Health Limited (PGHL) - Total Assets

Latest as of September 2025: Rs8.94 Billion INR ≈ $96.73 Million USD

Based on the latest financial reports, Procter & Gamble Health Limited (PGHL) holds total assets worth Rs8.94 Billion INR (≈ $96.73 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore Procter & Gamble Health Limited cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Procter & Gamble Health Limited - Total Assets Trend (2003–2024)

This chart illustrates how Procter & Gamble Health Limited's total assets have evolved over time, based on quarterly financial data. See Procter & Gamble Health Limited shareholders equity for net asset value and shareholders' equity analysis.

Procter & Gamble Health Limited - Asset Composition Analysis

Current Asset Composition (December 2024)

Procter & Gamble Health Limited's total assets of Rs8.94 Billion consist of 66.3% current assets and 33.7% non-current assets.

Asset Category	Amount (INR)	% of Total Assets
Cash & Equivalents	Rs898.10 Million	23.7%
Accounts Receivable	Rs1.47 Billion	18.5%
Inventory	Rs1.09 Billion	13.8%
Property, Plant & Equipment	Rs1.22 Billion	15.4%
Intangible Assets	Rs7.10 Million	0.1%
Goodwill	Rs0.00	0.0%

Asset Composition Trend (2003–2024)

This chart illustrates how Procter & Gamble Health Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see how much is Procter & Gamble Health Limited worth.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Procter & Gamble Health Limited's current assets represent 66.3% of total assets in 2024, an increase from 48.6% in 2003.
Cash Position: Cash and equivalents constituted 23.7% of total assets in 2024, up from 0.3% in 2003.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2003.
Asset Diversification: The largest asset category is accounts receivable at 18.5% of total assets.

Procter & Gamble Health Limited Competitors by Total Assets

Key competitors of Procter & Gamble Health Limited based on total assets are shown below.

Company	Country	Total Assets
Takeda Pharmaceutical Company Limited F:TKDA	Germany	€15.41 Trillion
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	China	CN¥19.57 Billion
Beijing Sun Novo Pharmaceutical Research Co Ltd SHG:688621	China	CN¥2.30 Billion
Guizhou Xinbang Pharmaceutical Co Ltd SHE:002390	China	CN¥8.59 Billion
Guangdong Lifestrong Pharmacy Co. Ltd. SHE:301111	China	CN¥925.41 Million
Jw Pharmac KO:001060	Korea	₩605.27 Billion
Kamada TA:KMDA	Israel	ILA377.21 Million
Samjin Pharm KO:005500	Korea	₩449.14 Billion

Procter & Gamble Health Limited - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	2.87	3.35	3.59
Quick Ratio	2.30	2.79	2.65
Cash Ratio	1.26	0.00	0.00
Working Capital	Rs4.17 Billion	Rs5.41 Billion	Rs4.24 Billion

Procter & Gamble Health Limited - Advanced Valuation Insights

This section examines the relationship between Procter & Gamble Health Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	14.25
Latest Market Cap to Assets Ratio	0.15
Asset Growth Rate (YoY)	0.0%
Total Assets	Rs7.94 Billion
Market Capitalization	$1.17 Billion USD

Valuation Analysis

Below Book Valuation: The market values Procter & Gamble Health Limited's assets below their book value (0.15x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: Procter & Gamble Health Limited's assets decreased by 0.0% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Procter & Gamble Health Limited (2003–2024)

The table below shows the annual total assets of Procter & Gamble Health Limited from 2003 to 2024.

Year	Total Assets	Change
2024-12-31	Rs7.94 Billion ≈ $85.89 Million	-0.02%
2023-12-31	Rs7.94 Billion ≈ $85.91 Million	-27.86%
2022-12-31	Rs11.01 Billion ≈ $119.09 Million	+23.21%
2021-12-31	Rs8.94 Billion ≈ $96.65 Million	-9.37%
2020-12-31	Rs9.86 Billion ≈ $106.65 Million	-16.17%
2019-12-31	Rs11.76 Billion ≈ $127.22 Million	-33.14%
2018-12-31	Rs17.59 Billion ≈ $190.28 Million	+77.50%
2017-12-31	Rs9.91 Billion ≈ $107.20 Million	+12.28%
2016-12-31	Rs8.83 Billion ≈ $95.47 Million	+12.61%
2015-12-31	Rs7.84 Billion ≈ $84.78 Million	+10.70%
2014-12-31	Rs7.08 Billion ≈ $76.59 Million	+9.19%
2013-12-31	Rs6.49 Billion ≈ $70.14 Million	+9.14%
2012-12-31	Rs5.94 Billion ≈ $64.27 Million	+18.94%
2011-12-31	Rs5.00 Billion ≈ $54.03 Million	+16.20%
2010-12-31	Rs4.30 Billion ≈ $46.50 Million	-24.32%
2009-12-31	Rs5.68 Billion ≈ $61.44 Million	+1.36%
2008-12-31	Rs5.61 Billion ≈ $60.62 Million	+14.50%
2007-12-31	Rs4.90 Billion ≈ $52.94 Million	+2.12%
2006-12-31	Rs4.79 Billion ≈ $51.84 Million	+23.73%
2005-12-31	Rs3.87 Billion ≈ $41.90 Million	+18.48%
2004-12-31	Rs3.27 Billion ≈ $35.36 Million	+17.60%
2003-12-31	Rs2.78 Billion ≈ $30.07 Million	--

About Procter & Gamble Health Limited

NSE:PGHL India Drug Manufacturers - Specialty & Generic

Market Cap

$1.17 Billion

Rs107.92 Billion INR

Market Cap Rank

#8154 Global

#410 in India

Share Price

Rs6501.50

Change (1 day)

-1.56%

52-Week Range

Rs4778.60 - Rs6918.50

All Time High

Rs6918.50